ClinicalTrials.gg
Not yet recruitingNCT07891754TIPC-ChinaUpdated Oct 23, 2026

Effects of a School-Based Trauma-Informed Psychosocial Competence Intervention on Nonsuicidal Self-Injury in Adolescents

An interventional study of Trauma-Informed Psychosocial Competence (TIPC) Program in Nonsuicidal Self-Injury, sponsored by Han Wu. Not yet recruiting. Open to participants aged 12 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Han Wu · Not applicable, Interventional, and Prevention

Updated Oct 23, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
6,000
Allocation
Randomized
Ages
12 Years and older
Sex
All
01

Study summary

The purpose of this randomized controlled trial is to evaluate whether a school-based Trauma-Informed Psychosocial Competence (TIPC) intervention can reduce nonsuicidal self-injury among adolescents in China. Nonsuicidal self-injury means deliberately injuring oneself without intending to die.

The TIPC program aims to help adolescents understand and accept themselves, manage difficult emotions, cope with stress, communicate with others, and seek support. It uses a trauma-informed approach that recognizes how stressful or adverse experiences may affect young people and emphasizes safety, respect, and supportive relationships.

The main question is whether adolescents receiving the TIPC program show a greater reduction in nonsuicidal self-injury than those in the comparison group. The study will also examine changes in emotional well-being and psychosocial functioning.

Participants will be assigned to an intervention group or a comparison group through random allocation. Adolescents in the intervention group will take part in structured school-based sessions. Participants in both groups will complete questionnaires before and after the intervention to assess self-injury and related psychological and social outcomes.

Read the detailed description

This study will evaluate a school-based Trauma-Informed Psychosocial Competence (TIPC) intervention using a randomized controlled design. The intervention combines trauma-informed principles with practical skills training to address modifiable emotional and interpersonal processes relevant to adolescent nonsuicidal self-injury.

The program was developed through a review of the literature, qualitative work, expert consultation using the Delphi method, and preliminary feasibility work. Its content focuses on self-awareness and self-acceptance, perspective-taking and empathy, emotion regulation, active coping and relaxation, communication and social interaction, support-seeking, and mental health literacy. The existing curriculum comprises eight adolescent group sessions and one caregiver-adolescent activity intended to strengthen supportive family interactions.

The trial will test whether participation in the program reduces nonsuicidal self-injury compared with the comparison condition. Changes in psychological symptoms, resilience, and social and behavioral functioning will also be evaluated to characterize the broader effects of the intervention.

Outcome assessments will use standardized self-report questionnaires administered to both study groups. The evaluation will focus on between-group differences in change from baseline, rather than changes within the intervention group alone.

The findings will inform the use of trauma-informed psychosocial skills education for adolescent self-injury prevention in school settings.

02

Conditions studied

  • Nonsuicidal Self-Injury

Keywords

  • Adolescent
  • School-Based Intervention
  • Trauma-Informed Care
  • Psychosocial Competence
  • Emotion Regulation
  • Self-Injury Prevention
  • Randomized Controlled Trial
  • TIPC
03

In context

Self-Injurious Behavior

259 studies on the registry are indexed under Self-Injurious Behavior; 95 are open to participants now.

This study's planned enrollment of 6,000 is above the median of 66 across 219 interventional studies indexed under Self-Injurious Behavior.

Browse Self-Injurious Behavior studies →

Lead sponsor

This is the only study on the registry with Han Wu as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Enrolled as a student in a participating school and within the grade levels selected for recruitment.
  • Able to understand the Chinese-language study materials and participate in the intervention activities and questionnaire assessments, with reasonable support where needed.
  • Willing to participate and provide informed assent or consent, as appropriate for age.
  • Written informed consent provided by a parent or legal guardian for participants below the applicable age of legal consent.

Exclusion criteria

Exclusion Criteria:

  • A condition that prevents informed assent or consent, participation in the intervention, or completion of the study assessments despite reasonable support.
  • Concurrent participation in another structured intervention trial targeting nonsuicidal self-injury that would conflict with participation in this study.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
6,000 participants (estimated)

Study arms

  • Experimental
    TIPC Intervention Group

    Participants in this group will receive the school-based Trauma-Informed Psychosocial Competence (TIPC) program. The program comprises eight adolescent group sessions and one caregiver-adolescent activity. Sessions address self-awareness and self-acceptance, empathy, emotion regulation, stress management, communication, support-seeking, and mental health literacy.

    Behavioral: Trauma-Informed Psychosocial Competence (TIPC) Program

  • No intervention
    Usual School Provision Control Group

    Participants in this group will continue to receive the education and support ordinarily available at their schools. No additional study-specific intervention will be provided to this group during the intervention period.

Interventions

  • BehavioralTrauma-Informed Psychosocial Competence (TIPC) Program

    A structured school-based psychosocial skills program guided by trauma-informed principles. The program aims to strengthen adolescents' emotional and interpersonal skills through eight adolescent group sessions and one caregiver-adolescent activity. Content includes self-awareness, self-acceptance, perspective-taking, empathy, emotion regulation, active coping, relaxation, communication, support-seeking, and mental health literacy. The caregiver-adolescent activity focuses on supportive family interactions.

06

What researchers measure

Primary outcomes

  1. Change From Baseline in Past-Month Nonsuicidal Self-Injury Behavior Frequency Score

    Past-month nonsuicidal self-injury (NSSI) behavior will be assessed using a self-report item measuring the frequency of deliberate self-injury without suicidal intent. Responses are scored from 0 to 4: 0 = never, 1 = once, 2 = 2-3 times, 3 = 4-5 times, and 4 = 6 or more times. Higher scores indicate more frequent NSSI behavior. Change will be calculated as the post-assessment score minus the baseline score; negative values indicate improvement. Changes will be compared between the intervention and control groups.

    Time frame: Baseline and Week 8/ Week 16

  2. Change From Baseline in Past-Month Nonsuicidal Self-Injury Thought Frequency Score

    Past-month thoughts of nonsuicidal self-injury will be assessed using a self-report item about thoughts of deliberately injuring oneself without suicidal intent. Responses are scored from 0 to 4: 0 = never, 1 = once, 2 = 2-3 times, 3 = 4-5 times, and 4 = 6 or more times. Higher scores indicate more frequent NSSI thoughts. Change will be calculated as the post-assessment score minus the baseline score; negative values indicate improvement. Changes will be compared between the intervention and control groups.

    Time frame: Baseline and Week 8/ Week 16

Secondary outcomes

  1. Change From Baseline in Patient Health Questionnaire-9 (PHQ-9) Total Score

    Depressive symptoms will be assessed using the 9-item Patient Health Questionnaire (PHQ-9). Each item is scored from 0 to 3, giving a total score of 0-27. Higher scores indicate more severe depressive symptoms. Change is calculated as the post-assessment score minus the baseline score; negative values indicate improvement.

    Time frame: Baseline and Week 8 & Week 16

  2. Change From Baseline in Generalized Anxiety Disorder-7 (GAD-7) Total Score

    Anxiety symptoms will be assessed using the 7-item Generalized Anxiety Disorder scale (GAD-7). Each item is scored from 0 to 3, giving a total score of 0-21. Higher scores indicate more severe anxiety symptoms. Change is calculated as the post-assessment score minus the baseline score; negative values indicate improvement.

    Time frame: Baseline and Week 8 & Week 16

  3. Change From Baseline in Connor-Davidson Resilience Scale-10 (CD-RISC-10) Total Score

    Resilience will be assessed using the 10-item Connor-Davidson Resilience Scale (CD-RISC-10). Each item is scored from 0 to 4, giving a total score of 0-40. Higher scores indicate greater resilience. Change is calculated as the post-assessment score minus the baseline score; positive values indicate improvement.

    Time frame: Baseline and Week 8 & Week 16

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided — There is no plan to share individual participant data with researchers outside the study team. The study involves adolescents and collects sensitive information on self-injury, childhood adversity, and mental health. This decision is intended to protect participant privacy and minimize the risk of re-identification. Study findings will be reported in aggregate form.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07891754
Lead sponsor
Han Wu
Collaborators
School of Medicine, Chongqing University
Responsible party
Han Wu (PhD student, Tokyo University) — Sponsor-investigator
First posted
Oct 23, 2026
Start date
Nov 2026 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Oct 23, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion